Outset Medical (OM) Cash from Investing Activities (2019 - 2026)

Outset Medical (OM) has reported Cash from Investing Activities for 8 consecutive years, with $14.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Investing Activities rose 145.46% year-over-year to $14.2 million in Q2 2026; TTM through Jun 2026 was $33.6 million, a 127.38% increase from a year earlier, with the FY2025 full-year figure at -$97.7 million, down 193.98% from the prior year.
• Cash from Investing Activities was $14.2 million for Q2 2026 at Outset Medical, up from $7.9 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $108.2 million in Q4 2024 and troughed at -$78.1 million in Q1 2025.
• A 5-year average of $2.5 million and a median of $8.2 million in 2025 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities jumped 2163.3% in 2023 and plunged 2333.48% in 2024, its largest moves.
• Over 5 years, Cash from Investing Activities stood at -$51.7 million in 2022, then jumped by 145.27% to $23.4 million in 2023, then surged by 361.7% to $108.2 million in 2024, then slumped by 92.06% to $8.6 million in 2025, then jumped by 64.91% to $14.2 million in 2026.
• The last three Cash from Investing Activities figures came in at $14.2 million (Q2 2026), $7.9 million (Q1 2026), and $8.6 million (Q4 2025), per Business Quant data.